This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2019 Nov 21;381(21):2063-2064.

doi: 10.1056/NEJMe1912180. Epub 2019 Sep 19.

Heart-Failure Therapy - New Drugs but Old Habits?

Affiliations

PMID: 31535828
DOI: 10.1056/NEJMe1912180

Editorial

Heart-Failure Therapy - New Drugs but Old Habits?

James C Fang. N Engl J Med. 2019.

. 2019 Nov 21;381(21):2063-2064.

doi: 10.1056/NEJMe1912180. Epub 2019 Sep 19.

Author

Affiliation

¹ From the Division of Cardiovascular Medicine, University of Utah Health, Salt Lake City.

PMID: 31535828
DOI: 10.1056/NEJMe1912180

No abstract available

PubMed Disclaimer

Comment on

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
McMurray JJV, Solomon SD, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, Bělohlávek J, Böhm M, Chiang CE, Chopra VK, de Boer RA, Desai AS, Diez M, Drozdz J, Dukát A, Ge J, Howlett JG, Katova T, Kitakaze M, Ljungman CEA, Merkely B, Nicolau JC, O'Meara E, Petrie MC, Vinh PN, Schou M, Tereshchenko S, Verma S, Held C, DeMets DL, Docherty KF, Jhund PS, Bengtsson O, Sjöstrand M, Langkilde AM; DAPA-HF Trial Committees and Investigators. McMurray JJV, et al. N Engl J Med. 2019 Nov 21;381(21):1995-2008. doi: 10.1056/NEJMoa1911303. Epub 2019 Sep 19. N Engl J Med. 2019. PMID: 31535829 Clinical Trial.

Similar articles

Building the Foundation for a New Era of Quadruple Therapy in Heart Failure.
Felker GM. Felker GM. Circulation. 2020 Jan 14;141(2):112-114. doi: 10.1161/CIRCULATIONAHA.119.044578. Epub 2019 Nov 17. Circulation. 2020. PMID: 31736333 No abstract available.
Understanding the Mechanistic Benefit of Heart Failure Drugs Matters.
Januzzi JL Jr, Ibrahim NE. Januzzi JL Jr, et al. J Am Coll Cardiol. 2020 Dec 8;76(23):2752-2754. doi: 10.1016/j.jacc.2020.10.026. J Am Coll Cardiol. 2020. PMID: 33272369 No abstract available.
Dapagliflozin - a breakthrough in the search for drugs to treat HFrEF.
Huynh K. Huynh K. Nat Rev Cardiol. 2019 Dec;16(12):700. doi: 10.1038/s41569-019-0291-1. Nat Rev Cardiol. 2019. PMID: 31578515 No abstract available.
[Are some antidiabetic drugs also drugs useful for heart failure treatment?].
Murín J. Murín J. Vnitr Lek. 2016 Apr;62(4):322-8. Vnitr Lek. 2016. PMID: 27250612 Review. Czech.
New drugs: big changes in conservative heart failure therapy?
Berliner D, Bauersachs J. Berliner D, et al. Eur J Cardiothorac Surg. 2019 Jun 1;55(Suppl 1):i3-i10. doi: 10.1093/ejcts/ezy421. Eur J Cardiothorac Surg. 2019. PMID: 31106335 Free PMC article. Review.

See all similar articles

Cited by

Excess long-term risk of adverse outcomes in heart failure patients with high and low levels of NT-proBNP: A 7-year follow-up study (NorthStar Trial).
Tuxen A, Malmborg M, Nouravesh N, Videbaek L, Malik M, Zahir D, Koeber L, Andersen CF, Butt JH, Jensen J, Foesbol E, Andersson C, Gustafsson F, Schou M. Tuxen A, et al. Int J Cardiol Heart Vasc. 2024 Jun 8;53:101441. doi: 10.1016/j.ijcha.2024.101441. eCollection 2024 Aug. Int J Cardiol Heart Vasc. 2024. PMID: 39228977 Free PMC article.
Specialized heart failure clinics versus primary care: Extended registry-based follow-up of the NorthStar trial.
Malmborg M, Assad Turky Al-Kahwa A, Kober L, Torp-Pedersen C, Butt JH, Zahir D, Tuxen CD, Poulsen MK, Madelaire C, Fosbol E, Gislason G, Hildebrandt P, Andersson C, Gustafsson F, Schou M. Malmborg M, et al. PLoS One. 2023 Jun 8;18(6):e0286307. doi: 10.1371/journal.pone.0286307. eCollection 2023. PLoS One. 2023. PMID: 37289772 Free PMC article. Clinical Trial.
Sodium-glucose co-transporter-2 drugs: are we sure they are useful only in the treatment of diabetes?
Vassiliki' Coutsoumbas G, Zagnoni S, Corona G, Di Pasquale G. Vassiliki' Coutsoumbas G, et al. Eur Heart J Suppl. 2020 Nov 18;22(Suppl L):L66-L71. doi: 10.1093/eurheartj/suaa138. eCollection 2020 Nov. Eur Heart J Suppl. 2020. PMID: 33654470 Free PMC article.
[Diabetes mellitus in old age].
Zeyfang A, Zeeh J, Bahrmann A, Kugler JN, Heppner HJ. Zeyfang A, et al. Z Gerontol Geriatr. 2021 Feb;54(1):61-71. doi: 10.1007/s00391-020-01815-1. Epub 2020 Nov 26. Z Gerontol Geriatr. 2021. PMID: 33242104 Free PMC article. German.
Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy.
Arow M, Waldman M, Yadin D, Nudelman V, Shainberg A, Abraham NG, Freimark D, Kornowski R, Aravot D, Hochhauser E, Arad M. Arow M, et al. Cardiovasc Diabetol. 2020 Jan 10;19(1):7. doi: 10.1186/s12933-019-0980-4. Cardiovasc Diabetol. 2020. PMID: 31924211 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information